Alpha & Omega Semiconductor Q2 FY25 Filing
Ticker: AOSL · Form: 10-Q · Filed: Feb 6, 2025 · CIK: 1387467
| Field | Detail |
|---|---|
| Company | Alpha & Omega Semiconductor Ltd (AOSL) |
| Form Type | 10-Q |
| Filed Date | Feb 6, 2025 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, earnings, semiconductors
TL;DR
AOSL Q2 FY25 10-Q filed. Check financials.
AI Summary
Alpha & Omega Semiconductor Ltd. reported its Q2 fiscal year 2025 results for the period ending December 31, 2024. The company's filing indicates a fiscal year end of June 30th. Key financial data points and segment information are included in this report.
Why It Matters
This 10-Q filing provides investors with the latest financial performance and operational details for Alpha & Omega Semiconductor Ltd. during the second quarter of fiscal year 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new risks disclosed.
Key Numbers
- 12,497 — Shares (Number of shares related to the filing.)
Key Players & Entities
- ALPHA & OMEGA SEMICONDUCTOR Ltd (company) — Filer
- 408-830-9742 (dollar_amount) — Business Phone
- 20241231 (date) — Period of Report
- 20250206 (date) — Filed as of Date
- 2024-07-01 (date) — Reporting Period Start Date
- 2024-12-31 (date) — Reporting Period End Date
FAQ
What is the company's fiscal year end?
The company's fiscal year ends on June 30th.
What is the filing date of this 10-Q?
This 10-Q was filed as of February 6, 2025.
What period does this 10-Q cover?
This 10-Q covers the period of report ending December 31, 2024.
What is the company's SIC code?
The Standard Industrial Classification code is 3674 for Semiconductors & Related Devices.
What is the company's business address?
The business address is 475 Oakmead Parkway, Sunnyvale, CA 94085.
Filing Stats: 4,779 words · 19 min read · ~16 pages · Grade level 17.8 · Accepted 2025-02-06 16:01:42
Filing Documents
- aosl-20241231.htm (10-Q) — 1554KB
- ex101fourthsupplementfro.htm (EX-10.1) — 1KB
- ex102fifthsupplementfron.htm (EX-10.2) — 1KB
- ex103fourthsupplementpro.htm (EX-10.3) — 1KB
- ex311-aosl12312024q2202510q.htm (EX-31.1) — 9KB
- ex312-aosl12312024q2202510q.htm (EX-31.2) — 9KB
- ex321-aosl12312024q2202510q.htm (EX-32.1) — 5KB
- ex322-aosl12312024q2202510q.htm (EX-32.2) — 6KB
- ex101fourthsupplementfro001.jpg (GRAPHIC) — 130KB
- ex102fifthsupplementfron001.jpg (GRAPHIC) — 180KB
- ex103fourthsupplementpro001.jpg (GRAPHIC) — 179KB
- 0001387467-25-000017.txt ( ) — 9581KB
- aosl-20241231.xsd (EX-101.SCH) — 66KB
- aosl-20241231_cal.xml (EX-101.CAL) — 104KB
- aosl-20241231_def.xml (EX-101.DEF) — 347KB
- aosl-20241231_lab.xml (EX-101.LAB) — 834KB
- aosl-20241231_pre.xml (EX-101.PRE) — 631KB
- aosl-20241231_htm.xml (XML) — 1234KB
FINANCIAL INFORMATION
Part I. FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements: 1 Condensed Consolidated Balance Sheets as of December 3 1 , 2024 and June 30, 2024 (Unaudited) 1 Condensed Consolidated Statements of Income (Loss) for the Three and Six Months Ended December 3 1 , 2024 and 2023 (Unaudited) 2 Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Six Months Ended December 3 1 , 2024 and 2023 (Unaudited) 3 Condensed Consolidated Statements of Changes in Shareholders' Equity for the Three and Six Months Ended December 3 1 , 2024 and 2023 (Unaudited) 4 Condensed Consolidated Statements of Cash Flows for the Six Months Ended December 3 1 , 2024 and 2023 (Unaudited) 6 Notes to Condensed Consolidated Financial Statements (Unaudited) 7
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 30
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 43
Controls and Procedures
Item 4. Controls and Procedures 43
OTHER INFORMATION
Part II. OTHER INFORMATION
Legal Proceedings
Item 1. Legal Proceedings 44
Risk Factors
Item 1A. Risk Factors 44
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 45
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 46
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 46
Other Information
Item 5. Other Information 46
Exhibits
Item 6. Exhibits 47
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Financial Statements
ITEM 1. Financial Statements ALPHA AND OMEGA SEMICONDUCTOR LIMITED CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in thousands except par value per share) December 31, 2024 June 30, 2024 ASSETS Current assets: Cash and cash equivalents $ 182,592 $ 175,127 Restricted cash 206 413 Accounts receivable, net 19,879 12,546 Inventories 183,733 195,750 Contract assets 8,451 — Other current assets 15,433 14,165 Total current assets 410,294 398,001 Property, plant and equipment, net 317,793 336,619 Operating lease right-of-use assets 23,317 25,050 Intangible assets, net 1,893 3,516 Equity method investment 357,941 356,039 Deferred income tax assets 540 549 Other long-term assets 22,166 25,239 Total assets $ 1,133,944 $ 1,145,013 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 40,816 $ 45,084 Accrued liabilities 71,392 72,371 Payable related to equity investee, net 18,137 13,682 Income taxes payable 2,943 2,798 Short-term debt 11,742 11,635 Deferred revenue — 2,591 Finance lease liabilities 970 935 Operating lease liabilities 5,032 5,137 Total current liabilities 151,032 154,233 Long-term debt 20,826 26,724 Income taxes payable - long-term 3,724 3,591 Deferred income tax liabilities 26,754 26,416 Finance lease liabilities - long-term 1,787 2,282 Operating lease liabilities - long-term 18,851 20,499 Other long-term liabilities 8,390 19,661 Total liabilities 231,364 253,406 Commitments and contingencies (Note 12) Shareholders' Equity: Preferred shares, par value $ 0.002 per share: Authorized: 10,000 shares; issued and outstanding: none at December 31, 2024 and June 30, 2024 — — Common shares, par value $ 0.002 per share: Authorized: 100,000 shares; issued and outstanding: 36,367 shares and 29,232 shares, respectively at December 31, 2024 and 36,107 shares and 28,969 shares, respectively at June 30, 2024 73 72 Treasury shares at cost: 7,135 shares at December 31, 2024 and 7,138 shares at June 30